Poor validity of self-reported HBV vaccination among young heroin users in Spain supports the policy "don't ask, draw a blood sample, vaccinate and try to schedule another visit"

J Clin Virol. 2007 Jan;38(1):87-90. doi: 10.1016/j.jcv.2006.09.013. Epub 2006 Nov 7.

Abstract

Objectives: To assess the validity of self-reported hepatitis B virus vaccination status in young heroin users.

Study design: Cross-sectional study among 949 street-recruited young injection heroin users (IHUs) and non-injection heroin users (NIHUs) in Madrid, Barcelona and Seville. Face-to-face interviews and dried blood spot tested for anti-HBc and anti-HBs. The validity of self-reported vaccination status was assessed comparing with the serological status. The percentage of agreement with the kappa (kappa) statistic and the positive predictive value were calculated.

Results: The percentage of agreement between self-reported and serologic vaccination status was 51.9% overall, with little difference by city (53.1% in Barcelona, 49.0% in Madrid and 51.5% in Seville) or between IHUs (51.3%) and NIHUs (53.0%). All the kappa scores were lower than 0.1. The positive predictive value of self-reports was less than 25% in all categories analysed, except in the city of Barcelona (37%). Among those who indicated that they had been vaccinated, 31% were actually susceptible.

Conclusions: In areas with a high prevalence of infection and rising coverage of vaccination the policy "don't ask, take a blood sample, give a dose of vaccine and try to schedule another visit" should be recommended in clinical practice.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Cross-Sectional Studies
  • Female
  • Health Policy*
  • Hepatitis Antibodies / blood
  • Hepatitis B / blood
  • Hepatitis B / prevention & control*
  • Hepatitis B Core Antigens / immunology
  • Hepatitis B Surface Antigens / immunology
  • Heroin*
  • Humans
  • Male
  • Spain
  • Substance Abuse, Intravenous*
  • Surveys and Questionnaires*
  • Urban Population
  • Vaccination*
  • Viral Hepatitis Vaccines / administration & dosage*

Substances

  • Hepatitis Antibodies
  • Hepatitis B Core Antigens
  • Hepatitis B Surface Antigens
  • Viral Hepatitis Vaccines
  • Heroin